Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges
Cancer Treatment Reviews · 2026-11 · 150 · 103203
DOI: 10.1016/j.ctrv.2026.103203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Zhiyu Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, PR China. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Lung Neoplasms, Antineoplastic Agents, Immunological. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Nanjing Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, PR China.
- Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, PR China. Electronic address: wangzhaoxia@njmu.edu.cn.
Förderung
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical University
- National Natural Science Foundation of China
Zitieren
APA
Liu, Z., Zhang, Y., Xue, M., & Wang, Z. (2026). Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges. Cancer Treatment Reviews, 150, 103203. https://doi.org/10.1016/j.ctrv.2026.103203
Vancouver
Liu Z, Zhang Y, Xue M, Wang Z. Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges. Cancer Treatment Reviews. 2026;150:103203. doi:10.1016/j.ctrv.2026.103203
BibTeX
@article{Liu2026,
author = {Liu, Zhiyu and Zhang, Yang and Xue, Man and Wang, Zhaoxia},
title = {Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {150},
pages = {103203},
doi = {10.1016/j.ctrv.2026.103203}
}
EUVIMED